期刊文献+

中低位直肠癌术前与术后同步放化疗的疗效比较 被引量:17

Comparation of Preoperative Chemoradiation with postoperative Chemoradiation for mid-low rectal cancer
原文传递
导出
摘要 目的:比较术前同步放化疗与术后同步放化疗对中低位直肠癌的临床疗效和毒性反应。方法:中低位局部晚期直肠癌36例行术前同步放化疗,同期41例先行根治术再行术后同步放化疗,术前和术后放射治疗的剂量为45-50Gy,分次剂量为1.8-2Gy/d,每周5 d。自放疗开始,给予5-Fu 400 mg/m2持续静脉泵入和CF200 mg静脉滴注,d1-4和d15-19。比较两组的临床疗效和毒性反应。结果:术前同步放化疗的保肛率明显高于术后同步放化疗组,而局部复发率和急性放射性消化道反应明显低于术后同步放化疗组(P<0.05)。术后的并发症和生存率在两组之间没有差别(P>0.05)。结论:中低位直肠癌术前同步放化疗可以提高保肛率,降低局部复发率和急性放射性消化道反应,值得临床推广。 Objective To compare the advantages of preoperative chemoradiotherapy with postoperative Chemoradiation mid-low locally advanced stage rectal cancer.Methods seventy-seven patients with mid-low locally advanced stage rectal cancer were randomly divided into two groups:Preoperative Chemoradiation group(n = 36) and postoperative Chemoradiation group(n = 41),receiving standard fluorouracil-based combined modality treatment,consisting of radiotherapy of 45-50 Gy plus infusional fluorouracil(400 mg/m2 days 1-4 and 15-19)and leucovorin(200 mg days 1-4 and 15-19).The survival rate,the sphincter-saving rate in operation,incidence and degree of acute side reaction of chemo-radiotherapy were compared between two groups.Results Compared with postoperative Chemoradiation group,the sphincter-saving rate in Preoperative Chemoradiation group significantly increased(P<0.05),but local recurrence rate and acute side reaction of gastrointestinal tract were significantly decreased(P<0.05),no significant difference in survival rates and postoperative complication between two groups(P>0.05).Conclusion Chemo-radiotherapy in Preoperative Chemoradiation was able to increasing the sphincter-saving rate,reducing local recurrence rate and t acute side reaction of gastrointestinal tract,which was worth of clinic generalization.
出处 《湖南师范大学学报(医学版)》 2012年第3期78-80,92,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 直肠癌 术前放化疗 术后放化疗 carcinoma of rectum preoperative chemoradiotherapy postoperative Chemoradiation
  • 相关文献

参考文献8

  • 1Bosset JF,Calais G,Mineur L. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer:Preliminary results-EORTC 22921[J].Journal of Clinical Oncology,2005,(24):5620-5627.
  • 2Gérard JP,Conroy T,Bonnetain F. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:Results of FFCD 9203[J].Journal of Clinical Oncology,2006,(28):4620-4625.
  • 3Wolmark N,Wieand HS,Hyams DM. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum:National Surgical Adjuvant Breast and Bowel Project Protocol R-02[J].Journal of the National Cancer Institute,2000,(05):388-396.
  • 4van Gijn W,Marijnen CA,Nagtegaal ID. Preoperative radiotherapy combined with total mesorectal excision for resectablerectal cancer:12-year follow-up of the multicentre,randomised controlled TME trial[J].Lancet Oncology,2011,(06):575-582.
  • 5Sebag-Montefiore D,StephensRJ,Steele R. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016):Amulticentre,randomised trial[J].Lancet,2009,(9666):811-820.
  • 6Mark S.Roh,Linda H.Colangelo,Michael J.O'Connell. Preoperative Multimodality Therapy Improves DiseaseFree Survival in Patients With Carcinoma of the Rectum:NSABP R-03[J].Journal of Clinical Oncology,2009,(31):5124-5130.
  • 7李革,李林虎,尹玩熙.直肠癌的术前单独放疗与联合放疗、化疗的疗效比较[J].中国临床医学,2007,14(4):510-511. 被引量:5
  • 8Minsky BD. Progress in the treatment of locally advanced clinically resectable rectal cancer[J].Clinical Colorectal Cancer,2011,(04):227-237.

二级参考文献10

  • 1Fisher B,Wolmark N,Rockette H,et al.Postoperative adjuvant chemotherapy for rectal cancer:Results from NSABP protocol R-01[J].JNCI,1988,80:21-29.
  • 2Pisani P,Parkin DM,Bray F,et al.Estimates of the worldwide mortality from 25 cancers in 1990[J].Int J Cancer,1999,83:18-19.
  • 3Hyams DM,Mamounas EP,Petrelli N,et al.A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum:a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03[J].Dis Colon Rectum,1997,40:131-139.
  • 4Jae SK,Seong HP,Wan HY,et al.Treatment results of preoperative radiotherapy alone vs.preoperative radiotherapy and chemotherapy in locally advanced rectal cancer[J].J Korean Soc Ther Padiol March,1995,13:33-39.
  • 5Raskov HH.Comined radiotherapy and chemotherapy as adjuvant treatment of rectal cancer[J].Ugeskr-laeger,1995,24:157:4223-4228.
  • 6Minsky BD,Coia L,Haller D,et al.Treatment systems guidelines for primary rectal cancer from the 1996 patterns of care study[J].Int J Radiol Oncol Biol Phys,1998,41:21 -27.
  • 7Janjan NA,Khoo VS,Abbruzzese J,et al.Tumor downstaging and sphincter preservation[J].Int J Radiat Oncol Biol Phy,1998,40:1027-1038.
  • 8Krook JE,Moertel CG,Gunderson LL,et al.Effective surgical adjuvant therapy for high-risk rectal carcinoma[J].N Engl J Med,1991,324:709-715.
  • 9Minsky BD,Cohen AM,Kemeny N,et al.Combinded modality therapy of rectal cancer:decreased acute toxicity with the pre-operative approach[J].J Clin Oncol,1992,10:1218-1224.
  • 10Olav D,Arild H,Inge M,et al.Low-dose preoperative radiation postpones recurrences in operable rectal cancer[J].Cancer September,1990,66:2286-2294.

共引文献4

同被引文献166

  • 1张卫东.低位直肠癌保肛术36例临床分析[J].中国医学工程,2011,19(2). 被引量:2
  • 2刘胜男,汤海燕.肠造口病人的个案管理[J].中国护理管理,2013,13(S1):170-170. 被引量:4
  • 3郑伯安,邹寿椿,邓高里,董全进,张成武.低位直肠癌术前放疗联合化疗的疗效观察[J].中华胃肠外科杂志,2004,7(5):378-380. 被引量:10
  • 4石全,邓晓军,熊春,郑绍光,韦敬以,蒙建强.低位直肠癌术前放化疗与手术治疗效果观察[J].广西医科大学学报,2005,22(6):961-962. 被引量:5
  • 5Endrizzi B, Ahmed RL,Ray T,et al. Capecitabine to reducenonmelanoma skin carcinoma burden in solid organ transplantrecipients[J].Dermatol Surg, 2013, 39(4):634-645.
  • 6Koeberle D, Burkhard R,von Moos R, et al.Phase IIstudy of capecitabine and oxaliplatin given prior to andconcurrently with preoperative pelvic radiotherapy in patientswith locally advanced rectal cancer[J].Br J Cancer, 2008,98(7):1204-1209.
  • 7Cassidy J,Clarke S, Diaz-Rubio E, et al.Randomizedphase HI study of capecitabine plus oxaliplatin comparedwith fluorouracil/folinic acid plus oxaliplatin as first-linetherapy for metastatic colorectal cancer[J]. J Clin Oncol,2008,26(12):2006-2012.
  • 8于进,王浩龙.新辅助治疗低位进展期直肠癌15例疗效观察[J].国际外科学杂志,2007,34(10):664-666. 被引量:1
  • 9Van Gijn W,Marijnen CA, Nagtegaal ID, et al. Preoperative radio- therapy combined with total mesorectal excision for resectablerectal cancer:12-year-follow-op of the multicentre, randomised controlled TME trial[ J]. Lancet Oncol,2011,12 (6) :575 - 582.
  • 10Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative ra- diotherapy versus selective postoperative chemoradiotherapy in pa- tients with rectal cancer (MRC CR07 and NCIC -CTG C016) :Am- nltieentre, randomised trial [ J]. Lancet,2009,373 ( 96 ) :811 - 820.

引证文献17

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部